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Abstract
Background: Internet based self-help for panic disorder (PD) has proven to be effective. However, studies so far
have focussed on treating a full-blown disorder. Panic symptoms that do not meet DSM-IV criteria are more
prevalent than the full-blown disorder and patients with sub-clinical panic symptoms are at risk of developing PD.
This study is a randomised controlled trial aimed to evaluate an Internet based self-help intervention for sub-
clinical and mild PD compared to a waiting list control group.
Methods: Participants with mild or sub-clinical PD (N = 128) will be recruited in the general population. Severity of
panic and anxiety symptoms are the primary outcome measures. Secondary outcomes include depressive
symptoms, quality of life, loss of production and health care consumption. Assessments will take place on the
Internet at baseline and three months after baseline.
Discussion: Results will indicate the effectiveness of Internet based self-help for sub-clinical and mild PD. Strengths
of this design are the external validity and the fact that it is almost completely conducted online.
Trial registration: Netherlands Trial Register (NTR): NTR1639 The Netherlands Trial Register is part of the Dutch
Cochrane Centre.
Background
A n x i e t yd i s o r d e r sa r eh i g h l yp r e v a l e n t ,a f f e c t i n go n ei n
six people during their lifetime [1], and cause a substan-
tial loss of quality of life [2]. Direct and indirect costs
caused by anxiety disorders are estimated at half a bil-
lion dollars per 1 million adults per year [3]. One of
those anxiety disorders is panic disorder (PD). A study
among the population in the Netherlands shows PD
affects 1.5% of all adults each year, while 2% of the
population is affected by sub-clinical PD [4]. Sub-clinical
PD indicates infrequent panic attacks or frequent panic
attacks that are relatively mild. It can be defined as
panic symptoms that do not meet DSM-IV criteria for
PD. Sub-clinical PD is a substantial burden for both the
patient and society [4]. Panic symptoms are often
comorbid with other mental health problems, like
depression or other anxiety disorders [5]. Comorbid
anxiety and depressive symptoms can lead to suicidal
ideation [6] and PD elevates the risk at suicide attempts
when comorbid with a mood disorder, substance abuse
or another anxiety disorder [7].
While PD can be effectively treated by cognitive beha-
vioural therapy and pharmacotherapy [8], it is known
that only 25% of people with anxiety symptoms seeks
help [9] and only 15% of people with panic symptoms
receives effective treatment [10]. Help-seeking might be
too difficult or fearful for people with panic symptoms,
especially when they suffer from agoraphobia as well. In
addition, help-seeking could be further compromised by
fear of stigmatisation, misinterpretation of panic symp-
toms as a physical problem, or little awareness of effec-
tive treatment opportunities or available services.
A more accessible and perhaps more acceptable alter-
native to face-to-face interventions for PD is Internet
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of Internet based self-help for PD [11-13]. Moreover,
Internet based self-help courses save clinicians’ time and
cost little compared to face-to-face treatment or phar-
macotherapy [14].
Internet based self-help interventions for panic symp-
toms focus mainly on full-blown PD [11-13]. An accessi-
ble self-help course, tailored for the large group of sub-
clinical and mild cases, would be beneficial to a group
of patients that is not yet targeted by Internet interven-
tions. Moreover, an Internet based self-help course for
sub-clinical and mild panic symptoms could close the
gap between prevention and early intervention of panic
disorder.
This study is designed to evaluate Don’t Panic Online
(Geen Paniek Online) [15], an Internet based self-help
course for sub-clinical and mild cases of PD with mini-
mal guidance. Don’t Panic Online (DPO) is based on
Don’tP a n i c( Geen Paniek) [16], a face-to-face group
course for sub-clinical and mild panic symptoms. Don’t
Panic has proven to be cost-effective [17,18].
We will conduct a randomised controlled trial, com-
paring an experimental group that takes the course
Don’t Panic Online to a waiting list control group that
will get access to an information website. The research
question is the following: what is the effect of the Inter-
net based self-help course Don’t Panic Online on sub-
clinical to mild panic symptoms?
Methods
Design
We will conduct a randomised controlled trial with two
arms: (a) Internet based self-help with minimal gui-
dance, (b) waiting list control group with information
website. The Medical and Ethical Committee of VU
Medical Centre approved the study protocol.
Study population
The study population consists of adults with sub-clini-
cal or mild PD. The inclusion criteria are the follow-
ing: 18 years of age or older, Internet access, sub-
clinical or mild PD (PDSS-SR score 5-15). Conse-
quently, individuals with too mild (PDSS-SR score 1-4)
or too severe (PDSS-SR score 15 or higher) panic
symptoms will be excluded. Participants who report
moderate to high suicide risk, as measured by a self-
report version of the MINI, will be excluded as well.
Applicants who report severe panic symptoms or sui-
cide risk will be contacted by e-mail and advised to
contact their general practitioner.
Sample size
Power calculations are based on a moderate effect size
of d=.50, comparing the PDSS-SR scores of the
intervention group to the control group with a two-
sided t-test (alpha .05, power 80%). To show this effect
each group will consist of 64 participants [19], so the
total sample size adds up to N = 128. Missing values
will be imputed using regression imputation.
Recruitment
Participants will be recruited in the general population
by means of a Facebook advertisement campaign, mes-
sages on panic or anxiety related online forums, banners
on health related websites and advertisements in news-
papers. Interested individuals will be directed to a study
website, where they can find further information as well
as an informed consent form. They can apply for parti-
cipation by printing and signing the informed consent
form, which can be scanned and sent by e-mail or sent
by postal mail. After application, the researchers will
send the participants a link to an online questionnaire.
Randomisation and procedure
After screening and completion of the baseline ques-
tionnaires (t0), the participant will be contacted for a
diagnostic interview by telephone. The interview will be
conducted within two weeks after baseline by a trained
and experienced interviewer. All participants will be ran-
domised to one of the two groups, regardless of the pre-
sence or absence of a diagnosis. Randomisation will be
stratified for the presence or absence of agoraphobia
symptoms (PDSS-SR item 4 score > 1) and the use of
medication. Randomisation lists are generated with a
computer program. Blinding of the participants and
researchers is not possible due to the design of this
research. The post-treatment assessment (t1) is sched-
uled at 3 months after baseline. Both the baseline and
the post-treatment assessments are self-report and will
be conducted through the Internet.
Intervention
Don’t Panic Online (DPO) is an individual guided web-
based self-help course, based on cognitive behavioural
therapy. It was developed by the Trimbos Institute,
which is the Netherlands Institute for Mental health and
Addiction, in collaboration with GGNet, a Dutch mental
health care institute. The course consists of six sessions,
in which the participants will learn to control their
panic symptoms by applying various cognitive beha-
vioural techniques and skills. The course’sf o r m a ti s
based on Colour Your Life, an evidence based Internet
intervention for depressive symptoms [20,21].
DPO is a protocolised treatment and consists of the
following components: keeping a log of panic attacks;
analysis of fearful situations; challenging thoughts that
enable feelings of panic; replacing these thoughts by
more realistic, constructive thoughts that reduce anxiety;
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ageable to difficult and carrying them out in order of
difficulty. Each session consists of text, voice over, ani-
mated diagrams and video. A typical session will take
about thirty minutes and consists of an introduction, a
discussion of the previous lesson’s homework, new the-
ory and homework for the next week. The course is
designed to be followed on a weekly basis until session
five, while the sixth lesson can be followed four weeks
after the fifth. The course can be completed in eight
weeks.
Besides the lessons, the participant has several online
resources at his or her disposal: a homework station, a
panic attack log, a library for extra information, reading
tips and a discussion board.
The DPO website contains an e-mail system for con-
tact between a participant and a coach. For the current
study, the coach will reply to questions about the
course, its exercises and the participant’s mental health.
He will also contact the user weekly to ask after his pro-
gress. Participants will be supported for a maximum of
three months. The coaches will consist of students who
are in the final phase of their study of clinical psychol-
ogy. All will receive a brief training.
Participants in the control group will receive access to
DPO after completing the t1 measurement. In the mean
time, they will have access to an information website
about PD.
Instruments
All variables will be measured at t0 and t1, except for
demographic data, the diagnosis and satisfaction with
the intervention. Demographic data and diagnosis are
only measured at t0, while satisfaction with the inter-
vention will only be measured at t1.
Demographic data
This section contains questions about age, gender and
education.
Diagnosis
The Composite International Diagnostic Interview
(CIDI) [22] will be used to ascertain the presence or
absence of PD, other anxiety disorders and depression.
The CIDI has been developed by the WHO and is an
extensive, fully structured diagnostic interview to assess
DSM-IV Axis-I diagnoses [22]. Only the subscales
depression, PD, agoraphobia, GAD, social phobia and
post-traumatic stress disorder will be used in this study.
The reliability of these subscales is sufficient (inter-rater
 = .94 - .99; test-retest  = .62 - .84) [23]. In this
study, a trained interviewer will administer the CIDI by
telephone.
Anxiety and panic symptoms
For severity of panic symptoms the Panic Disorder
Severity Scale - Self Report (PDSS-SR) will be used. The
PDSS is originally a face-to-face interview [24] and was
adapted to self-report by Houck et al. [25]. The instru-
ment contains seven items that assess the severity of
seven dimensions of panic disorder and associated
symptoms. The PDSS-SR generates a total score ranging
from 0 to 28, with a higher score indicating more severe
panic symptoms. The questionnaire has good psycho-
metric properties with Cronbach’sa l p h a=0 . 9 2a n d
intraclass correlation coefficient = 0.81 [25]. In the cur-
rent study, a score of 0-4 will count as no clinically rele-
vant symptoms and 16 or higher as severe PD.
Anxiety symptoms in general will be measured with
the Beck Anxiety Inventory (BAI) [26]. The BAI con-
tains 21 short questions. Internal consistency is high,
with Cronbach’s alpha ranging from .90 to .94 [26]. The
score varies from 0 to 63. A score of 30 or higher is
interpreted as severe anxiety symptoms.
Depressive symptoms
Depressive symptoms we will be measured with the
CES-D [27]. The CES-D is a 20-item self-report ques-
tionnaire. Every item ranges from 0 to 3 and the total
score ranges from 0 (no feelings of depression) to 60
(severe feelings of depression). Radloff [27] reports high
internal consistencies among different populations (.79
to .92). The optimal cut-off score varies between 16 and
27 [28]. In the current study, we will regard 27 and
higher as a high score.
Suicidal risk
Suicidal risk and ideation will be measured with the spe-
cific section of the Mini-International Neuropsychiatric
Interview (MINI) [29,30]. The MINI suicide section con-
sists of 6 items and classifies subjects into four groups:
no suicidal risk, low suicidal risk, moderate suicidal risk,
and high suicidal risk. In this study, the items are self-
report. Participants with moderate to high suicidal risk
will be excluded from this study.
Quality of life
Quality of life will be measured with the Dutch version
of the EuroQol Questionnaire (EQ-5D) [31,32]. This
short list contains five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression.
The EQ-5 D generates a total of 243 unique health
states, each of which is associated with a utility score
ranging from 0 (poor health) to 1 (perfect health). The
EQ-5 D is a validated instrument for measuring general
health-related quality of life [31-33].
Loss of production and health care consumption
An indication of loss of production and use of care will
be made with the Trimbos and Institute of Medical
Technology Assessment Questionnaire on Costs Asso-
ciated with Psychiatric Illness (TiC-P) [34]. This list
consists of three parts. Part I measures health care con-
sumption of individuals who suffer from mental disor-
ders. Part II examines loss of production (indirect costs)
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rent study, part III will be omitted, because demo-
graphic variables are already measured elsewhere.
Satisfaction and track-and-trace
A track-and-trace system will keep a record of the dates
participants of the intervention group log on or finish a
lesson. This system will also pose a question after each
lesson: “W a st h i sl e s s o nu s e f u lt oy o u ? ”, which can be
answered on a 5-point Likert scale. At t1, these partici-
pants will receive questions about their experience with
the intervention. This includes the number of lessons
followed, the amount of time spent on homework, satis-
faction with the intervention and satisfaction with the
coaching.
Analyses
Differences in demographic and baseline clinical char-
acteristics will be computed with Chi-square tests, t-
tests, and analysis of variance (ANOVA). The data of
post-treatment measurements will be analysed in
agreement with the intention to treat principle.
Assuming missing data will be missing at random, the
Linear Mixed Modeling (LMM) procedure will be used
for all analyses to estimate missing values. LMM
includes incomplete cases in the analysis and employs
restricted maximum likelihood estimation to calculate
parameter estimates.
Effects between the experimental and control group
on continuous measures will be calculated with Cohen’s
d. Cohen’s d is computed by subtracting the mean post-
test score of the control group from the average score
of the experimental group and dividing the difference by
the pooled standard deviation. Effect sizes of 0.8 can be
assumed to be large, while effect sizes of 0.5 are moder-
ate, and effect sizes of 0.2 are small [35]. Estimated data
from the LMM procedure will be used to analyse effect
sizes.
Discussion
Internet based self-help for PD has proven to be effec-
tive. However, existing interventions focus on treating a
full-blown disorder, while sub-clinical PD is highly pre-
valent and can develop into full-blown PD. This study is
a randomised controlled trial aimed to evaluate an
Internet based self-help intervention for sub-clinical and
mild PD compared to a waiting list control group. The
primary outcome measure is the severity of panic and
anxiety symptoms. Secondary outcome measures include
depression, quality of life, loss of production and health
care consumption.
Methodological considerations
The primary research question is whether DPO is an
effective intervention for mild and sub-clinical PD. We
hypothesise the experimental group will show more
improvement on the outcome measures than the control
group, because the experimental group receives an
accessible intervention tailored for its specific mental
health problems.
A limitation of this study is the low number of exclu-
sion criteria. The presence of a comorbid disorder or
substance abuse is not an exclusion criterion. Comor-
bidity may influence this study’s outcome measures,
because panic symptoms may not be the participant’s
primary mental health problem. However, in reality,
many people who suffer from panic symptoms have
comorbid mental health problems, especially other anxi-
ety disorders and depression [6]. Therefore, it is prefer-
able not to exclude participants based on DSM
diagnoses for these disorders. An indication of the
effects of comorbidity on the effectiveness of DPO could
be obtained by mediator analyses.
Both a strength and a limitation of this study is that,
apart from the diagnostic interview, the measurements
are conducted online. Some evidence suggests psycho-
metric properties may change when a test is conducted
via the web [36,37]. Consequently, results of this study
may differ from studies into panic interventions that
applied paper-pencil questionnaires. On the other hand,
the strength of online self-report measurements is the
accessibility of participation [38]. Therefore, this study is
feasible and should be able to answer the research
questions.
Conclusion
Existing online interventions for panic symptoms focus
on treating full-blown PD, while sub-clinical PD is
highly prevalent and may develop into a full-blown dis-
order. This study evaluates an Internet based self-help
intervention for sub-clinical and mild PD. Results will
contribute to the ongoing research into Internet based
interventions and treatment of panic symptoms.
Acknowledgements and funding
Godelief Willemse, Jessica Herzmanatus and Peter Meulenbeek have
contributed to the content of Don’t Panic Online.
This study is funded by the Trimbos Institute and VU-University Amsterdam.
Author details
1Department of clinical psychology and EMGO Institute, VU-University,
Amsterdam, The Netherlands.
2Trimbos Institute (Netherlands Institute of
Mental Health and Addiction), Utrecht, The Netherlands.
3GGZ InGeest,
Amsterdam, The Netherlands.
Authors’ contributions
All authors have contributed to, read and approved this manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 November 2010 Accepted: 11 March 2011
Published: 11 March 2011
van Ballegooijen et al. Trials 2011, 12:75
http://www.trialsjournal.com/content/12/1/75
Page 4 of 5References
1. Somers JM, Goldner EM, Waraich P, Hsu L: Prevalence and incidence
studies of anxiety disorders: a systematic review of the literature. Can J
Psychiatry 2006, 51(2):100-13.
2. Angermeyer MC, Kilian R, Wilms HU, Wittmund B: Quality of life of spouses
of mentally ill people. Int J Soc Psychiatry 2006, 52(3):278-85.
3. Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A: Costs
of nine common mental disorders: implications for curative and
preventive psychiatry. J Ment Health Policy Econ 2006, 9(4):193-200.
4. Batelaan N, Smit F, de Graaf R, van Balkom A, Vollebergh W, Beekman A:
Economic costs of full-blown and subthreshold panic disorder. J Affect
Disord 2007, 104(1-3):127-36.
5. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE: Prevalence,
severity, and comorbidity of 12-month DSM-IV disorders in the National
Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):617-27.
6. Norton PJ, Temple SR, Pettit JW: Suicidal ideation and anxiety disorders:
Elevated risk or artifact of comorbid depression? J Behav Ther Exp
Psychiatry 2008, 39(4):515-25.
7. Nock MK, Hwang I, Sampson NA, Kessler RC: Mental disorders,
comorbidity and suicidal behavior: Results from the National
Comorbidity Survey Replication. Mol Psychiatry 2010, 15(8):868-76.
8. Furukawa TA, Watanabe N, Churchill R: Psychotherapy plus antidepressant
for panic disorder with or without agoraphobia. Br J Psychiatry 2006,
188:305-12.
9. Roness A, Mykletun A, Dahl AA: Help-seeking behaviour in patients with
anxiety disorder and depression. Acta Psychiatr Scand 2005, 111(1):51-8.
10. Craske MG, Zucker BG: Consideration of the apa practice guideline for
the treatment of patients with panic disorder: strengths and limitations
for behavior therapy. Behavior Therapy 2001, 32:259-281.
11. Carlbring P, Bohman S, Brunt S, Buhrman M, Westling BE, Ekselius L,
Andersson G: Remote treatment of panic disorder: a randomized trial of
Internet-based cognitive behavior therapy supplemented with
telephone calls. Am J Psychiatry 2006, 163(12):2119-25.
12. Marks IM, Kenwright M, McDonough M, Whittaker M, Mataix-Cols D: Saving
clinicians’ time by delegating routine aspects of therapy to a computer:
a randomized controlled trial in phobia/panic disorder. Psychol Med 2004,
34(1):9-17.
13. Klein B, Richards JC, Austin DW: Efficacy of Internet therapy for panic
disorder. J Behav Ther Exp Psychiatry 2006, 37(3):213-38.
14. Cuijpers P, Marks IM, van Straten A, Cavanagh K, Gega L, Andersson G:
Computer-Aided Psychotherapy for Anxiety Disorders: A Meta-Analytic
Review. Cogn Behav Ther 2009, , 2: 66-82.
15. Kramer J, Conijn B, Herzmanatus J, Riper H: Productbeschrijving Geen Paniek
Online Utrecht: Trimbos-instituut; 2008.
16. Meulenbeek P, Herzmanatus J, Smit F, Willemse G, Van der Zanden R:
Cursusmap: Geen Paniek, leren omgaan met paniekklachten Utrecht: Trimbos-
instituut/GGNet; 2005.
17. Meulenbeek P, Willemse G, Smit F, van Balkom A, Spinhoven P, Cuijpers P:
Early intervention in panic: randomized controlled trial and cost-
effectiveness analysis. Trials 2008, 27(9):67.
18. Smit F, Willemse G, Meulenbeek P, Koopmanschap M, van Balkom A,
Spinhoven P, Cuijpers P: Preventing panic disorder: cost-effectiveness
analysis alongside a pragmatic randomised trial. Cost Eff Resour Alloc
2009, 24(7):8.
19. Lipsey MW: Design sensitivity; statistical power for experimental research
Newbury Park: Sage publications; 1993.
20. Warmerdam L, van Straten A, Twisk J, Riper H, Cuijpers P: Internet-based
treatment for adults with depressive symptoms: randomized controlled
trial. J Med Internet Res 2008, 10(4):e44.
21. Spek V, Cuijpers P, Nyklícek I, Smits N, Riper H, Keyzer J, Pop V: One-year
follow-up results of a randomized controlled clinical trial on internet-
based cognitive behavioural therapy for subthreshold depression in
people over 50 years. Psychol Med 2008, 38(5):635-9.
22. Robins LN, Wing J, Wittchen HU, Helzer JE, Babor TF, Burke J, Farmer A,
Jablenski A, Pickens R, Regier DA, et al: The Composite International
Diagnostic Interview. An epidemiologic Instrument suitable for use in
conjunction with different diagnostic systems and in different cultures.
Arch Gen Psychiatry 1988, 45(12):1069-77.
23. Wittchen HU: Reliability and validity studies of the WHO–Composite
International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res
1994, 28(1):57-84.
24. Shear MK, Rucci P, Williams J, Frank E, Grochocinski V, Vander Bilt J,
Houck P, Wang T: Reliability and validity of the panic disorder severity
scale: replication and extension. J Psychiatr Res 2001, 35(5):293-6.
25. Houck PR, Spiegel DA, Shear MK, Rucci P: Reliability of the self-report
version of the Panic Disorder Severity Scale. Depress Anxiety 2002,
15:183-185.
26. Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical
anxiety: psychometric properties. J Consult Clin Psychol 1988, 56(6):893-7.
27. Radloff LS: The CES-D Scale: A self-report depression scale for research in
the general population. Appl Psychol Meas 1977, 1:385.
28. Haringsma R, Engels GI, Beekman AT, Spinhoven P: The criterion validity of
the Center for Epidemiological Sutdies Depression Scale (CES-D) in a
sample of self-referred elders with depressive symptomatology. Int J
Geriatr Psychiatry 2004, 19(6):558-63.
29. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E,
Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric
Interview (M.I.N.I.): the development and validation of a structured
diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry
1998, 59(Suppl 20):22-33, quiz 34-57.
30. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan KH,
Janavs J, Dunbar G: The Mini International Neuropsychiatric Interview
(MINI). A short diagnostic structured interview: reliability and validity
according to the CIDI. European Psychiatry 1997, 12:224-231.
31. Brooks R: EuroQol: the current state of play. Health Policy 1996,
37(1):53-72.
32. De Beurs E, den Hollanders-Gijsman ME, Buwalda V, Trijsburg W, Zitman FG:
De Outcome Questionnaire OQ-45. Psychodiagnostisch gereedschap. De
Psycholoog 2005, 40:393-400.
33. Fransen M, Edmonds J: Reliability and validity of the EuroQol in patients
with osteoarthritis of the knee. Rheumatology 1999, 38(9):807-13.
34. Hakkaart-van Roijen L, van Straten A, Donker M, Tiemens B: Handleiding
Trimbos/iMTA questionnaire for Costs associated with Psychiatric illness (TiC-P)
Rotterdam: Insituut voor Medische Technology Assessment, Erasmus MC;
2002.
35. Cohen J: Statistical Power Analysis for the Behavioural Sciences. 2 edition.
Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
36. Buchanan T, Ali T, Heffernan TM, Ling J, Parrott AC, Rodgers J, Scholey AB:
Nonequivalence of On-Line and Paper-and-Pencil Psychological Tests:
The Case of the Prospective Memory Questionnaire. Behav Res Methods
2005, 37(1):148-54.
37. Cuijpers P, Boluijt P, Van Straten A: Screening of depression in adolescents
through the Internet: sensitivity and specificity of two screening
questionnaires. Eur Child Adolesc Psychiatry 2008, 17:32-38.
38. Whitehead LC: Methodological issues in Internet-mediated research in
the field of health: An integrated review of the literature. Soc Sci Med
2007, 65:782-791.
doi:10.1186/1745-6215-12-75
Cite this article as: van Ballegooijen et al.: The effects of an Internet
based self-help course for reducing panic symptoms-Don’t Panic
Online: study protocol for a randomised controlled trial. Trials 2011
12:75.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
van Ballegooijen et al. Trials 2011, 12:75
http://www.trialsjournal.com/content/12/1/75
Page 5 of 5